Grant for accessing biospecimens and research data from the Population Assessment of Tobacco and Health (PATH) Study on tobacco use in the U.S.
Funder: National Institutes of Health
Due Dates: April 30, 2025 | October 31, 2025 | April 30, 2026 | October 30, 2026
Funding Amounts: No direct funding; award is access to PATH Study biospecimens and associated data for up to 5 years.
Summary: Provides researchers with access to biospecimens and data from the PATH Study to advance tobacco-related research in the U.S.
Key Information: Applicants must contact the PATH Study team at least 5 months before the deadline to confirm biospecimen availability and obtain a required confirmation letter.
This opportunity enables investigators to apply for access to biospecimens (urine, plasma, serum, and genomic DNA) and related research data from the Population Assessment of Tobacco and Health (PATH) Study. The PATH Study is a large, ongoing, nationally representative longitudinal cohort study of tobacco use, behaviors, attitudes, exposures, and health outcomes in the U.S., designed to inform tobacco regulatory science and public health policy. The biospecimens and data are intended to support meritorious research projects that align with PATH Study objectives, particularly those advancing tobacco regulatory science.